ADMA Biologics Ownership | Who Owns ADMA Biologics?
ADMA Biologics Ownership Summary
ADMA Biologics is owned by 76.13% institutional investors, 1.87% insiders, and 22.01% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.46% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.01% of its assets in ADMA Biologics shares.
ADMA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ADMA Biologics | 76.13% | 1.87% | 22.01% |
| Sector | Healthcare Stocks | 35.64% | 12.08% | 52.28% |
| Industry | Biotech Stocks | 35.26% | 12.00% | 52.74% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 36.83M | 15.46% | $331.85M |
| Vanguard group | 20.85M | 8.74% | $380.39M |
| Blackrock | 18.64M | 8.15% | $208.45M |
| State street | 14.08M | 5.91% | $126.90M |
| Capital research global investors | 11.19M | 4.70% | $100.83M |
| Nuveen | 6.10M | 2.56% | $54.95M |
| Geode capital management | 5.82M | 2.44% | $52.48M |
| Citadel advisors | 5.81M | 2.44% | $52.35M |
| Dimensional fund advisors lp | 5.01M | 2.10% | $45.10M |
| American century companies | 4.79M | 2.01% | $43.15M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| B group | 3.21M | 21.43% | $28.90M |
| Caligan partners lp | 4.76M | 2.85% | $42.86M |
| Stonepine capital management | 740.00K | 2.67% | $6.67M |
| Ophir asset management pty | 1.26M | 2.27% | $18.40M |
| Oberweis asset management inc/ | 2.71M | 1.52% | $39.76M |
| Ranger investment management | 2.28M | 1.49% | $20.58M |
| First light asset management | 1.07M | 1.48% | $15.67M |
| Mesirow institutional investment management | 782.45K | 1.03% | $13.42M |
| Marathon capital management | 532.35K | 0.90% | $4.46M |
| Clarivest asset management | 575.25K | 0.66% | $6.43M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital research global investors | 11.19M | 0.02% | 4.55M |
| Citadel advisors | 5.81M | 0.01% | 4.29M |
| Point72 asset management | 3.29M | 0.04% | 2.89M |
| Millennium management | 3.43M | 0.01% | 2.76M |
| Jane street group | 3.05M | 0.00% | 2.59M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sachem head capital management lp | - | - | -11.38M |
| Invesco | 4.12M | 0.01% | -7.67M |
| Westfield capital management co lp | - | - | -6.99M |
| Janus henderson group | 98.26K | 0.00% | -3.84M |
| Thrivent financial for lutherans | 158.86K | 0.00% | -3.63M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Rubric capital management lp | 1.81M | 0.17% | 1.81M | $16.30M |
| Vanguard fiduciary trust | 1.64M | 0.00% | 1.64M | $14.75M |
| Jupiter asset management | 711.51K | 0.03% | 711.51K | $6.41M |
| Clearline capital lp | 556.05K | 0.26% | 556.05K | $5.01M |
| Ashford capital management | 361.50K | 0.40% | 361.50K | $3.26M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Mendota financial group | -4.00 |
| Global wealth strategies & associates | -5.00 |
| Assetmark | -5.00 |
| Vermillion wealth management | -12.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 318 | -14.29% | 181,408,566 | -17.67% | 76 | 0.89% | 166 | -17.82% | 106 | -10.92% |
| Dec 31, 2025 | 122 | -68.06% | 37,183,315 | -83.04% | 15 | 0.19% | 65 | -60.37% | 34 | -78.48% |
| Sep 30, 2025 | 154 | -58.93% | 47,734,498 | -76.76% | 19 | 0.27% | 60 | -74.36% | 68 | -33.98% |
| Jun 30, 2025 | 376 | 4.16% | 204,872,171 | 0.17% | 84 | 1.15% | 230 | 18.56% | 107 | -6.96% |
| Mar 31, 2025 | 357 | 8.51% | 204,309,752 | 0.18% | 85 | 1.14% | 192 | -4.00% | 113 | 9.71% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 13.97M | 6.01% | 2.40K |
| American Funds SMALLCAP World A | 10.28M | 4.43% | 4.98M |
| First Trust NYSE Arca Biotech ETF | 7.82M | 3.37% | -137.86K |
| State Street® SPDR® S&P® Biotech ETF | 7.76M | 3.34% | -172.38K |
| Vanguard Total Stock Mkt Idx Inv | 7.03M | 3.02% | -158.62K |
| Vanguard US Total Market Shares ETF | 7.15M | 3.01% | 281.42K |
| iShares Russell 2000 ETF | 6.03M | 2.59% | 35.77K |
| American Century Small Cap Growth Inv | 3.36M | 1.45% | 200.08K |
| American Century U.S. Small Cap Growth | 3.36M | 1.45% | 200.08K |
| SPDR® S&P Biotech ETF | 3.25M | 1.36% | 7.24K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 27, 2026 | Grossman Jerrold B | - | Buy | $50.62K |
| May 12, 2026 | Grossman Jerrold B | - | Buy | $100.13K |
| May 11, 2026 | Grossman Jerrold B | - | Buy | $100.13K |
| Mar 16, 2026 | Grossman Adam S | President and CEO | Sell | $227.40K |
| Mar 16, 2026 | Grossman Adam S | President and CEO | Sell | $90.96K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | 3 | - |
| 2026 Q1 | 2 | 5 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 6 |
ADMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools